Structural, Compositional, and Dielectric State Profiling in Label‐Free Single‐Cell Monitoring
Small Methods · 2026-07 · 10 (13)
DOI: 10.1002/smtd.70759 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Small Methods, online erschienen am 03.06.2026. Verfasst von Changi Baek und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Chemical Engineering, Sungkyunkwan University, Suwon, Republic of Korea. Hauptthemen laut MEDLINE: Single-Cell Analysis. Die Arbeit nennt 158 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Alchemist Project of the Korea Evaluation Institute of Industrial Technology, Bio&Medical Technology Development Program of the National Research Foundation, Korean government (MSIT).
Abstract (Originalsprache)
Individual cells sense and transition between functional states, and the distribution of these states over time determines drug response, disease progression, and cell manufacturing outcomes. However, repeated measurement is difficult with label‐based acquisition, as photobleaching, phototoxicity, and probe‐induced perturbation accumulate. Label‐free monitoring that leverages intrinsic physical signals circumvents these constraints, shifting the analytical burden from label chemistry to instrumental drift. In this review, we organize this field into three measurement modalities, including imaging‐based, vibrational spectroscopy‐based, and electrical sensing‐based, each linked to distinct intrinsic state variables. Anchoring each modality to biological state variables such as structural organization, molecular composition, or dielectric architecture enables a physics‐grounded framework that clarifies how intrinsic signals map onto functional cellular phenotypes in longitudinal monitoring. We describe the measurement principle, drift sources, and feature space for each modality, and evaluate representative platforms against a frame spanning design, feature definition, quantitative performance, and validation practice. Dominant analytical constraints differ systematically across modalities, motivating integrative architectures in which complementary modalities resolve ambiguities that no single modality can disentangle. We further discuss shared requirements for calibration, standardized reporting, and multimodal integration, and outline requirements in hardware miniaturization, edge inference, and artificial intelligence‐guided molecular attribution to support scalable quantitative single‐cell phenotyping.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- School of Chemical Engineering, Sungkyunkwan University, Suwon, Republic of Korea.
- Division of Hematology-Oncology, Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea.
- Samsung Precision Genome Medicine Institute, Samsung Medical Center, Seoul, Republic of Korea.
ORCID-Profile: Changi Baek, Youngho Song, Seongcheol Park, Sujin Hyung, Sang Eun Yoon, Yong Jae Shin, Soo-Yeon Cho
Förderung
- Alchemist Project of the Korea Evaluation Institute of Industrial Technology
- Bio&Medical Technology Development Program of the National Research Foundation
- Korean government (MSIT)
Zitieren
APA
Baek, C., Song, Y., Park, S., Hyung, S., Yoon, S. E., Shin, Y. J., & Cho, S. Y. (2026). Structural, Compositional, and Dielectric State Profiling in Label‐Free Single‐Cell Monitoring. Small Methods, 10(13). https://doi.org/10.1002/smtd.70759
Vancouver
Baek C, Song Y, Park S, Hyung S, Yoon SE, Shin YJ, et al. Structural, Compositional, and Dielectric State Profiling in Label‐Free Single‐Cell Monitoring. Small Methods. 2026;10(13). doi:10.1002/smtd.70759
BibTeX
@article{Baek2026,
author = {Baek, Changi and Song, Youngho and Park, Seongcheol and Hyung, Sujin and Yoon, Sang Eun and Shin, Yong Jae and Cho, Soo-Yeon},
title = {Structural, Compositional, and Dielectric State Profiling in Label‐Free Single‐Cell Monitoring},
journal = {Small Methods},
year = {2026},
volume = {10},
number = {13},
doi = {10.1002/smtd.70759}
}
EUVIMED